Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-790P (RNA, U6 small nuclear 790, pseudogene) is a genomic DNA segment closely related to the U6 small nuclear RNA gene family, arising through retrotransposition and classified as a processed pseudogene[1][4]. Unlike functional U6 snRNA, which is crucial for the spliceosome and pre-mRNA splicing, RNU6-790P does not encode a functional RNA product and is not transcribed into an active small nuclear RNA. U6 snRNA pseudogenes, like RNU6-790P, are common in the vertebrate genome and reflect evolutionary processes such as LINE-1 mediated retrotransposition, rather than biological activity or disease relevance[4][3]. If your focus is on therapeutic targets, you should refer instead to functional snRNAs such as "U6 small nuclear RNA" rather than pseudogenes like RNU6-790P[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 790, pseudogene (RNU6-790P).